ID: h-var-9662d2e636
Hypothesis

SREBF2 Direct Activator Hyper-Lipidation Strategy

This strategy targets the upstream transcriptional control of cholesterol homeostasis by directly activating SREBF2 (SREBP-2) to simultaneously enhance ABCA1 expression while overriding miR-33-mediated suppression.
🧬 SREBF2/ABCA1🩺 molecular-biology🎯 Composite 38%promoted
molecular biology
EvidencePending (0%)📖 8 cit🗣 1 debates 4 support 4 oppose
✓ All Quality Gates Passed
Mechanistic 0.70 (15%) Evidence 0.29 (15%) Novelty 0.00 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.55 (10%) Safety 0.45 (8%) Competition 0.50 (6%) Data Avail. 0.70 (5%) Reproducible 0.65 (5%) KG Connect 0.12 (8%) 0.380 composite

🧪 Overview

This strategy targets the upstream transcriptional control of cholesterol homeostasis by directly activating SREBF2 (SREBP-2) to simultaneously enhance ABCA1 expression while overriding miR-33-mediated suppression. Unlike antisense approaches that block miR-33 post-transcriptionally, this mechanism leverages pharmacological SREBF2 super-activation to create a transcriptional flood that overwhelms miR-33 inhibitory capacity through sheer mRNA abundance. Small molecule activators or modified LXR agonists would target SREBF2's proteolytic processing machinery, forcing constitutive nuclear translocation and DNA binding even under cholesterol-replete conditions. This approach exploits the co-transcriptional relationship between SREBF2 and miR-33, where massive SREBF2 activation paradoxically produces both increased ABCA1 mRNA and increased miR-33, but the stoichiometric imbalance favors net ABCA1 protein production. The molecular rationale centers on saturating RISC complexes with excess miR-33 while simultaneously providing surplus ABCA1 transcripts that escape silencing.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["miR-33 Antisense<br/>Oligonucleotide"] --> B["ABCA1 Repression<br/>Relief"]
    B --> C["ABCA1 Expression<br/>Upregulation"]
    C --> D["Cholesterol/Phospholipid<br/>Efflux Increase"]
    D --> E["APOE4 Particle<br/>Hyper-Lipidation"]
    E --> F["Lipid Cargo<br/>Density Increase"]
    F --> G["APOE4-A-beta<br/>Binding Affinity Restoration"]
    G --> H["Enhanced A-beta<br/>Clearance"]
    H --> I["Amyloid Plaque<br/>Reduction"]
    I --> J["Neuroprotection"]
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style J fill:#1b5e20,stroke:#81c784,color:#81c784
    style E fill:#4a148c,stroke:#ce93d8,color:#ce93d8

⚖️ Evidence

⚖️ Evidence Matrix4 supports4 contradicts
Supports
CRISPR editing of miR-33 restores APOE lipidation and A-beta metabolism in ApoE4 models
Supports
miR-33 directly targets ABCA1 and regulates APOE lipidation in brain
Supports
Elevated miR-33 expression in AD patients, particularly APOE4 carriers
Supports
miR-33 antagonism enhances reverse cholesterol transport and reduces atherosclerosis
Contradicts
The 2024 study used genetic deletion from birth rather than pharmacological inhibition in adults - developmental compensation may explain results
Contradicts
Liver toxicity is major concern: miR-33 inhibition causes hepatic steatosis in mouse models
Contradicts
ABCA1 upregulation may not normalize APOE4 specifically due to structural domain interaction defect
Contradicts
BBB penetration of antisense oligonucleotides remains technically challenging for chronic CNS treatment
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — SREBF2

No curated PDB or AlphaFold mapping for SREBF2 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for SREBF2/ABCA1 from GTEx v10.

Cerebellum161 Cerebellar Hemisphere147 Cortex108 Frontal Cortex BA9107 Anterior cingulate cortex BA2487.7 Amygdala65.5 Hypothalamus61.1 Nucleus accumbens basal ganglia59.4 Hippocampus57.2median TPM (GTEx v10)

💉 Clinical Trials (1)

0
Active
0
Completed
0
Total Enrolled
Unknown·

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for SREBF2 →

No DepMap CRISPR Chronos data found for SREBF2.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline
4.5 years

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

💾 Resource Usage

LLM Tokens
5,428
$0.0163
Total Cost
$0.0163
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.